Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment

Flotillin‐1(FLOT1) has long been recognized as a tumour‐promoting gene in several types of cancer. However, the expression and function of FLOT1 in glioblastomas (GBM) has not been elucidated. Here, in this study, we find that the expression level of FLOT1 in GBM tissue was much higher than that in normal brain, and the expression was even higher in the more aggressive subtypes and IDH status of glioma. Kaplan–Meier survival revealed that high FLOT1 expression is closely associated with poor outcome in GBM patients. FLOT1 knockdown markedly reduced the proliferation, migration and invasiveness of GBM cells, while FLOT1 overexpression significantly increases GBM cell proliferation, migration and invasiveness. Mechanistically, FLOT1 expression may play a potential role in the microenvironment of GBM. Therefore, FLOT1 promotes GBM proliferation and invasion in vitro and in vivo and may serve as a biomarker of prognosis and therapeutic potential in the fight against GBM.

[1]  B. Bu,et al.  Case Report: Clinical and Imaging Characteristics of a Patient with Anti-flotillin Autoantibodies: Neuromyelitis Optica or Multiple Sclerosis? , 2021, Frontiers in Immunology.

[2]  Susan M. Chang,et al.  Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  W. Yung,et al.  Molecular Mechanisms of Treatment Resistance in Glioblastoma , 2020, International journal of molecular sciences.

[4]  C. Angeles,et al.  Memory CD8+ T cell responses to cancer. , 2020, Seminars in immunology.

[5]  Zev A. Binder,et al.  A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity , 2019, Cell.

[6]  V. Niggli,et al.  In Vivo Function of the Lipid Raft Protein Flotillin-1 during CD8+ T Cell–Mediated Host Surveillance , 2019, The Journal of Immunology.

[7]  G. Reifenberger,et al.  Molecular targeted therapy of glioblastoma. , 2019, Cancer treatment reviews.

[8]  V. Niggli,et al.  In vivo function of the lipid raft protein Flotillin 1 during CD8+ T cell-mediated host surveillance , 2018, bioRxiv.

[9]  Matthew Collin,et al.  Human dendritic cell subsets: an update , 2018, Immunology.

[10]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[11]  Devin P. Sullivan,et al.  A subcellular map of the human proteome , 2017, Science.

[12]  Pornpimol Charoentong,et al.  Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.

[13]  T. Wurdinger,et al.  Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[14]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[15]  Libing Song,et al.  Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells. , 2012, Gastroenterology.

[16]  Wymke Ockenga,et al.  Transcriptional Regulation of Flotillins by the Extracellularly Regulated Kinases and Retinoid X Receptor Complexes , 2012, PloS one.

[17]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[18]  Libing Song,et al.  Knockdown of FLOT1 Impairs Cell Proliferation and Tumorigenicity in Breast Cancer through Upregulation of FOXO3a , 2011, Clinical Cancer Research.

[19]  P. Fallon,et al.  Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment , 2010, The Journal of cell biology.

[20]  M. Frick,et al.  Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase , 2009, Journal of Cell Science.

[21]  D. Jacobowitz,et al.  Flotillin-1 in the substantia Nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain , 2009, Neurotoxicity Research.

[22]  D. Jayne,et al.  Laser microdissection expression profiling of marginal edges of colorectal tumours reveals evidence of increased lactate metabolism in the aggressive phenotype , 2008, Gut.

[23]  R. Tikkanen,et al.  Dissecting the molecular function of reggie/flotillin proteins. , 2007, European journal of cell biology.

[24]  S. Robbins,et al.  The SPFH domain-containing proteins: more than lipid raft markers. , 2007, Trends in cell biology.

[25]  C. Stuermer,et al.  Scaffolding microdomains and beyond: the function of reggie/flotillin proteins , 2005, Cellular and Molecular Life Sciences CMLS.

[26]  J. Renau‐Piqueras,et al.  PTOV1 Enables the Nuclear Translocation and Mitogenic Activity of Flotillin-1, a Major Protein of Lipid Rafts , 2005, Molecular and Cellular Biology.

[27]  G. Schmitz,et al.  Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. , 2004, Molecular biology of the cell.

[28]  B. Dubois,et al.  Accumulation of flotillin‐1 in tangle‐bearing neurones of Alzheimer's disease , 2003, Neuropathology and applied neurobiology.

[29]  J. Tschopp,et al.  Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation , 2003 .

[30]  D. Schadendorf,et al.  Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity. , 2002, Cancer research.

[31]  G. Plautz,et al.  Potent Effector Function of Tumor-Sensitized L-Selectinlow T Cells against Subcutaneous Tumors Requires LFA-1 co-Stimulation , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[32]  M. Kanzaki,et al.  CAP defines a second signalling pathway required for insulin-stimulated glucose transport , 2000, Nature.

[33]  H. Lodish,et al.  Flotillin and Epidermal Surface Antigen Define a New Family of Caveolae-associated Integral Membrane Proteins* , 1997, The Journal of Biological Chemistry.